Maravai LifeSciences
MRVI
MRVI
228 hedge funds and large institutions have $5.36B invested in Maravai LifeSciences in 2021 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 89 increasing their positions, 59 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
14.26% less ownership
Funds ownership: 111.7% → 97.44% (-14%)
14% less capital invested
Capital invested by funds: $6.27B → $5.36B (-$907M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
228
Holding in Top 10
2
Calls
$11.4M
Puts
$4.57M
Top Buyers
| 1 | +$353M | |
| 2 | +$103M | |
| 3 | +$59.5M | |
| 4 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
+$59.1M |
| 5 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
+$38.8M |
Top Sellers
| 1 | -$217M | |
| 2 | -$75.6M | |
| 3 | -$65.1M | |
| 4 |
DCP
D1 Capital Partners
New York
|
-$49.1M |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$48.2M |